IFNG and neoplasm: Stimulation of ILKAP KO cells with IFN-γ and TNFα revealed that ILKAP-mediated tumor protection against CTL killing is independent from controlling INF-γ or TNFα sensitivity, changing PD-L1 levels and regulating antigen presentation.